Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$172.7 - $214.93 $759,880 - $945,692
4,400 New
4,400 $815,000
Q2 2024

Aug 14, 2024

BUY
$133.83 - $251.19 $428,256 - $803,808
3,200 New
3,200 $428,000
Q4 2023

Feb 14, 2024

SELL
$125.26 - $203.83 $75,156 - $122,298
-600 Reduced 23.08%
2,000 $406,000
Q3 2023

Nov 15, 2023

BUY
$185.0 - $326.08 $166,500 - $293,472
900 Added 52.94%
2,600 $515,000
Q2 2023

Aug 14, 2023

BUY
$226.52 - $324.64 $90,608 - $129,856
400 Added 30.77%
1,700 $551,000
Q1 2023

May 15, 2023

BUY
$229.06 - $278.01 $45,812 - $55,602
200 Added 18.18%
1,300 $304,000
Q4 2022

Feb 14, 2023

SELL
$164.02 - $259.76 $196,824 - $311,712
-1,200 Reduced 52.17%
1,100 $275,000
Q3 2022

Nov 14, 2022

BUY
$170.68 - $226.46 $392,564 - $520,858
2,300 New
2,300 $409,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.1B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.